Navigation Links
New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
Date:1/11/2008

SKILLMAN, N.J., Jan. 11 /PRNewswire/ -- According to the American Academy of Dermatology (AAD), 10-20 percent of the world's population suffers from eczema, an inflamed skin condition characterized by red, scaly and itchy skin. To help manage the condition's symptoms, which tend to flare up in the winter months, AVEENO(R), the leader in ACTIVE NATURALS(R), has introduced the Eczema Care Moisturizing Cream and Body Wash, formulated with hydrating ingredients to help manage the daily symptoms of eczema and improve the skin's natural barrier function.

The AVEENO(R) Eczema Care products were developed with leading dermatologists and pediatric dermatologists to offer mild formulas suitable for both adults and babies, that are perfect for everyday use. AVEENO(R) Eczema Care products are specially formulated with Natural Colloidal Oatmeal and Pure Oat Essence to help lock moisture into the skin and soothe symptoms such as red, irritated and itchy skin. Additionally, the Moisturizing Cream includes a patented Triple Oat formula of key ingredients to help maintain the skin's barrier and provide moisturization for a full 24 hours. The products are also steroid free.

"We have conducted extensive research in order to develop this proprietary Triple Oat formula to manage eczema symptoms," says Judith Nebus, manager of clinical research for skin care at AVEENO(R). "Key ingredients in the patented formula, including Ceramides and Panthenol, moisturize and help protect the skin's barrier to help prevent the recurrence of redness, irritation and extra dry skin."

In a clinical study, 100% of subjects who used the AVEENO(R) Eczema Care Moisturizing Cream twice a day showed improvement in roughness in one week. In a separate clinical study, subjects who used the AVEENO(R) Eczema Care products showed significant improvements in itching and skin scaling after one week of use.

Additionally, 89% of consumers found that the Moisturizing Cream helped them m
'/>"/>

SOURCE AVEENO(R)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Positive Results Published Using AtriCure Minimally Invasive Products
2. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
3. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
4. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
5. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
6. FDA Confirms Seizure of Eyelash Product Was Not Prompted by Reports of Adverse Effects
7. Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/ -- Reportlinker.com announces that a new market..., United States Dental Devices Market Analysis ...ker.com/p0158733/United-States-Dental-Devices-Mark...ed States Dental Devices Market Analysis and Forec...an essential source for in-depth information and d...
(Date:11/25/2009)...PRNewswire/ -- Swissray International, Inc. a lead...dR ) systems, announced today that its operations ...h a long term view towards growing Swissray,s medi...sets and intellectual property, as well as contrac...owth Swissray is now poised to move to the next le...
(Date:11/25/2009)...Newswire/ -- Cempra Pharmaceuticals Inc. today ann...hief executive officer, will present at the Piper ... a.m. EST, December 1, 2009, at The New York Palac...ide an overview of the company,s two leading antib...resistant pathogens including MRSA. ,, About C...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Swissray International Announces New Ownership 2Sweet corn story begins in UW Madison lab 10828 1Sweet corn story begins in UW Madison lab 10828 2Sweet corn story begins in UW Madison lab 10828 3Laser therapy can aggravate skin cancer 61777 1NORD Letter to Senate Urges Action on Health Care Reform 61773 1NORD Letter to Senate Urges Action on Health Care Reform 61773 2
...rst Scientific Presentation for Pristiq Occurs at ...ollege of Obstetricians and,Gynecologists, COLLEGE... Wyeth,Pharmaceuticals, a division of Wyeth , pres...ating Pristiq(TM) (desvenlafaxine) for,the treatme...lashes,and night sweats) associated with menopause...
...RT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 9, 2007 ...oday announced positive,results from several studi... form of age-related macular degeneration (wet AMD... were presented this,week at the annual meeting of...lmology (ARVO). The data reported at the meeting,f...
Other Medicine Technology:Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 2VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 3VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 4VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 5
(Date:11/27/2009)...e-FirstCall/ -- GSI Group Inc. (Pink Sheets: GSIGQ...gy products and semiconductor systems, today annou...holders has been scheduled for Friday, April 30, 2... announced in due course. As previously announced...tephen Bershad, a holder of greater than ten perce...
(Date:11/27/2009)...irstCall/ -- The Gymboree Corporation (Nasdaq: GY...resent at the NASDAQ OMX 23rd Investor Program, wh...England, on Wednesday, December 2, 2009, at 11:45 ...he Gymboree Corporation,s presentation over the In...n "Our Company" at the bottom of the page, go to "...
(Date:11/27/2009)... announced that it has become a national sponsor o...profit organizations dedicated to arthritis resear... Delray Beach, FL (Vocus) November 27, 200...any specializing in the marketing and retail distr...nced today that is has become a national sponsor o...
(Date:11/27/2009)...announced today that Spectrum Health (Grand Rapids...orthopedic templating solution and its TraumaCad E... (PRWEB) November 27, 2009 -- Voyant Health&trade...ds, Michigan) has licensed its TraumaCad Enterpris... Extend workflow solution, to allow its orthopedic...
(Date:11/26/2009)...ith cold and flu season upon us, it,s more importa...he spread of infections and avoid illness. ,, "... healthy, but to avoid transmitting illness if we,...ied in infection-control), nursing director for in...l for Special Surgery (HSS) in Manhattan. ,, Ho...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...ssional sports clubs do not run regular comprehens...h published ahead of print in the British Journal ... on survey results from 65 professional clubs, cov... not legally obliged as employers to carry out hea...
...elhi, Prime Minister Dr. Manmohan Singh will inaug... supply and sanitation here on Wednesday. ...ity in drinking water supply projects and sanitati...issues of sustainability and convergence, water qu...
...of the ponds which have been around for thousands ...obal warming , according to two researchers. Ancie...summer as warmer temperatures evaporate shallow bo... John P. Smol of Queens University in Kings...
... United Nations agencies on Tuesday launched an ap...o help combat "alarming levels" of malnutrition a... in Kenya. The UN High Commissioner for Re...cent in Kenya's Dadaab complex of three camps and ...
...rs exploring choices made by childless couples fac...y they had uncovered important clues about mood s...sion. IVF, sometimes called 'test-tube bab...en be implanted into the womb. An importan...
...ementary therapies in assisted reproduction may di...infertility in women, was found by a scientist in... Human Reproduction and Embryology in Lyon, France...d complementary therapies were more negatively aff...
Other Medicine News:Health News:UK Sports Clubs Failing to Run Comprehensive Health Checks on Professional Players 2Health News:Pond in High Artic Drying Up Due to Global Warming 2Health News:Test-tube Babies: Mood Swings are Key to Fertility Choice 2Health News:Complementary Therapy may Reduce Pregnancy Chances in Women 2
MONOJECT Royal Blue Stopper (Powdered Additive)
BD Vacutainer® Specialty Tubes - Trace Element - Glass
MONOJECT Red Stopper (Non-Coated Tube)
BD Vacutainer® Plus Plastic Serum Tubes - Plastic
Medicine Products: